We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Noninvasive Device Detects Anemia

By LabMedica International staff writers
Posted on 13 Aug 2012
Print article
A noninvasive device will help screen women with anemia in developing nations. The low-cost screening device connected to a cell phone could save thousands of women and children from anemia-related deaths and disabilities.

The device, HemoGlobe, is designed to convert the existing cell phones of health workers into a "prick-free" system for detecting and reporting anemia at the community level. The device's sensor, placed on a patient's fingertip, shines different wavelengths of light through the skin to measure the hemoglobin level in the blood. On a phone's screen, a community health worker quickly sees a color-coded test result, indicating cases of anemia, from mild to moderate and severe.

If anemia is detected, a patient would be encouraged to follow a course of treatment, ranging from taking iron supplements to visiting a clinic or hospital for treatment. After each test, the phone would send an automated text message with a summary of the results to a central server, which would produce a real-time map showing where anemia is prevalent. This information could facilitate follow-up care and help health officials to allocate resources where the need is most urgent.

Developed by Johns Hopkins biomedical engineering (Baltimore, MD, USA) undergraduates, HemoGlobe offers a noninvasive way to identify women with anemia in developing nations. Soumyadipta Acharya, assistant research professor in Johns Hopkins' Department of Biomedical Engineering and the project's faculty advisor and principal investigator, said the device could be important in reducing anemia-related deaths in developing countries. International health experts estimate that anemia contributes to 100,000 maternal deaths and 600,000 newborn deaths annually.

The HemoGlobe student inventors have estimated their cell phone-based systems could be produced for USD 10 to USD 20 each. At the recent Saving Lives at Birth: A Grand Challenge for Development competition, a USD 250,000 seed grant was awarded to the Johns Hopkins students' project.

"The first year we just focused on proving that the technology worked," said 21year old team member Noah Greenbaum, of Watchung (NJ, USA). "Now, we have a greater challenge: to prove that it can have a real impact by detecting anemia and making sure the mothers get the care they need."

"The team members realized that every community health worker already carries a powerful computer in their pocket–their cell phone," Prof. Acharya said. "So we didn't have to build a computer for our screening device, and we didn't have to build a display. Our low-cost device will use the existing cell phones of health workers to estimate and report hemoglobin levels."

Related Links:

Johns Hopkins biomedical engineering


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Vitamin B12 Test
CHORUS CLIA VIT B12
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.